Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The tight junction protein complex at the blood–brain barrier (BBB) is a specialized assembly of transmembrane and cytoplasmic proteins that seal the paracellular space between endothelial cells (PMID: 23415110). Key components include claudins (especially claudin-5), occludin, and junctional adhesion molecules (JAMs), which are linked to the actin cytoskeleton via zonula occludens (ZO) scaffolding proteins (PMID: 12535520). This complex is essential for maintaining the high electrical resistance and selective permeability of the BBB, protecting the brain from toxins and pathogens while regulating nutrient transport (PMID: 28844075). Dysfunction of these proteins is a hallmark of several neurological disorders, including stroke, multiple sclerosis, and Alzheimer's disease, where barrier breakdown contributes to edema and neurodegeneration (PMID: 30124561). In drug development, this complex is a target for transient modulation to allow the passage of large or polar therapeutic agents into the brain (PMID: 21917916). Conversely, stabilizing these junctions is a therapeutic strategy to treat conditions characterized by excessive BBB permeability and neuroinflammation (PMID: 19233542).
Transient disruption of paracellular seals through osmotic stress, receptor-mediated signaling (e.g., Adenosine A2A or Bradykinin B2 agonism), or direct modulation of junctional proteins to facilitate drug delivery to the central nervous system (PMID: 21917916, StatPearls: Osmotic Diuretics).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tight junction protein complex at the blood–brain barrier (BBB-TJ complex).